Ibuprofeno Aurovitas (Ibuprofen)

Ibuprofen works by reversibly inhibiting the cyclooxygenase‑1 and cyclooxygenase‑2 (COX‑1/COX‑2) enzymes. This inhibition blocks the conversion of arachidonic acid to prostaglandins, which are mediators of pain, fever, and inflammation. Lower prostaglandin levels reduce nociceptor sensitisation, lower hypothalamic temperature set‑point, and diminish inflammatory swelling.

The appropriate dose of Ibuprofeno Aurovitas is determined by the prescribing healthcare professional based on the patient’s age, weight, clinical condition, and response to therapy. Dosage regimens may vary, and patients should follow the specific instructions provided by their prescriber or pharmacist.

Safety of ibuprofen during pregnancy and lactation depends on the trimester and individual risk factors. It is generally avoided in the third trimester because of potential fetal cardiovascular effects, and caution is advised earlier in pregnancy. Breastfeeding mothers should consult a healthcare provider, as ibuprofen does pass into breast milk in small amounts.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity of Ibuprofeno Aurovitas. GNH India works with hospitals, pharmacies and procurement teams worldwide, and will request verification of trade or institutional credentials. After confirmation, the team provides pricing, availability, shipping details and any necessary import documentation.

Ibuprofeno Aurovitas offers a familiar NSAID profile similar to other ibuprofen‑based products, providing effective analgesic, antipyretic and anti‑inflammatory actions with a relatively short half‑life. Compared with agents such as naproxen or diclofenac, ibuprofen generally has a quicker onset but may require more frequent dosing. Choice among NSAIDs depends on individual patient tolerance, comorbidities and physician preference.

Store Ibuprofeno Aurovitas at ambient temperature, preferably below 25 °C (77 °F). Keep the product in its original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed to maintain stability throughout its shelf life.

Ibuprofeno Aurovitas is taken orally, usually with a full glass of water. It can be taken with food or milk to lessen gastrointestinal discomfort, although it may also be taken on an empty stomach if tolerated. Patients should swallow the tablet whole and not crush or chew it unless specifically instructed by a healthcare professional.

Serious risks include gastrointestinal ulceration or bleeding, especially in patients with a history of ulcers or who use anticoagulants. Renal impairment can occur, particularly in dehydrated individuals or those with pre‑existing kidney disease. Cardiovascular events such as myocardial infarction or stroke may be heightened with long‑term use, and severe allergic reactions like anaphylaxis are possible but rare.

Ibuprofeno Aurovitas should be avoided in individuals with known hypersensitivity to ibuprofen or any other NSAIDs, those with active gastrointestinal bleeding or ulcer disease, severe renal or hepatic impairment, and patients in the third trimester of pregnancy. Caution is also advised for patients with uncontrolled hypertension, heart failure, or a history of cardiovascular disease.